Shin-Ichi Kosugi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shin-Ichi Kosugi has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
Katsuyoshi Hatakeyama
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata 951-8510, Japan
46 shared publicationsTakashi Ishikawa
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
31 shared publicationsTatsuo Kanda
Department of Surgery, Sanjo General Hospital, 5-1-62 Tsukanome, Sanjo-shi, Niigata 955-0055, Japan
26 shared publicationsKazuhito Yajima
Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan
25 shared publications- Tatsuo Kanda
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
23 shared publications - Toshifumi Wakai
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
20 shared publications
Latest Publications
- 25 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 6, 79-83
Three-Dimensional Shape Statistical Analysis of Tibial Plafond Deformed by Ankle Osteoarthritis
The etiology of primary ankle osteoarthritis is not enough elucidated. Ankle osteoarthritis wears away cartilage and causes pain in daily life same as the hip and knee osteoarthritis. However, the prognosis of ankle osteoarthritis is less favorable than hip and knee osteoarthritis. The investigation of the bone shape in ankle osteoarthritis is significant in choosing adequate surgery for patients. Choosing appropriate surgery leads to improving prognosis. X-ray images and Computed Tomography (CT)-scan images are usually used for the classification of ankle osteoarthritis, however, the classification by the two-dimensional measurements of the X-ray images and CT images can vary between physicians. The aim of this study is to investigate the three-dimensions geometrical deformity characteristics of the tibial plafond by statistical analysis. High severity ankle osteoarthritis had deformity characteristics. In particular, statistically significant differences were found in the varus deformity of the articular facet of medial malleolus and tibial plafond between stage 3B and mild group (p < 0.006), and the hyperostosis of the edge of anterior tibial plafond and the medial malleolus between stage 4 and mild group (p < 0.002). The results suggest that patients with high severity ankle osteoarthritis have tibial plafond common deformity characteristics. This study contributes to scientific advances in ankle osteoarthritis surgery.
- 25 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 6, 79-83
Three-Dimensional Shape Statistical Analysis of Tibial Plafond Deformed by Ankle Osteoarthritis
The etiology of primary ankle osteoarthritis is not enough elucidated. Ankle osteoarthritis wears away cartilage and causes pain in daily life same as the hip and knee osteoarthritis. However, the prognosis of ankle osteoarthritis is less favorable than hip and knee osteoarthritis. The investigation of the bone shape in ankle osteoarthritis is significant in choosing adequate surgery for patients. Choosing appropriate surgery leads to improving prognosis. X-ray images and Computed Tomography (CT)-scan images are usually used for the classification of ankle osteoarthritis, however, the classification by the two-dimensional measurements of the X-ray images and CT images can vary between physicians. The aim of this study is to investigate the three-dimensions geometrical deformity characteristics of the tibial plafond by statistical analysis. High severity ankle osteoarthritis had deformity characteristics. In particular, statistically significant differences were found in the varus deformity of the articular facet of medial malleolus and tibial plafond between stage 3B and mild group (p < 0.006), and the hyperostosis of the edge of anterior tibial plafond and the medial malleolus between stage 4 and mild group (p < 0.002). The results suggest that patients with high severity ankle osteoarthritis have tibial plafond common deformity characteristics. This study contributes to scientific advances in ankle osteoarthritis surgery.
- 5 April 2021
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 14 (4) , 767-774
Feasibility and educational value of fluorescence cholangiography in laparoscopic cholecystectomy
Introduction: Near‐infrared fluorescence cholangiography during a laparoscopic cholecystectomy has become widely accepted as a useful auxiliary tool to visualize the extrahepatic biliary structures. We investigated the feasibility and educational value of a method with longer interval between the administration of indocyanine green and the imaging of these structures.Methods: Approximately 18 hours before their surgery, patients (n = 51) were intravenously administered 0.25 mg/kg of indocyanine green. Each laparoscopic cholecystectomy was performed under fluorescence imaging in combination with white‐light imaging. Operative outcomes including visualization of the extrahepatic biliary structures and operative time were compared between the patients on whom board‐certified surgeons operated (feasibility phase; n = 18) and the patients on whom a surgery resident operated (educational phase; n = 33).Results: There were no adverse events related to the longer interval method. The visualization rates of extrahepatic biliary structures were comparable between the two phases. Both the mean time to divide the cystic duct and the mean time to remove the gallbladder in the educational phase were significantly longer than those in the feasibility phase (68.2 vs 24.4 minutes and 30.2 vs 15.8 minutes, P < .001 each). There was no significant difference in other operative outcomes. The operative time learning curve did not decrease with a resident's experience.Conclusions: Fluorescence cholangiography with the longer interval method was feasible and could identify the extrahepatic biliary structures irrespective of the surgeon's experience; however, it did not decrease the operative time with experience.
- 5 April 2021
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 14 (4) , 767-774
Feasibility and educational value of fluorescence cholangiography in laparoscopic cholecystectomy
Introduction: Near‐infrared fluorescence cholangiography during a laparoscopic cholecystectomy has become widely accepted as a useful auxiliary tool to visualize the extrahepatic biliary structures. We investigated the feasibility and educational value of a method with longer interval between the administration of indocyanine green and the imaging of these structures.Methods: Approximately 18 hours before their surgery, patients (n = 51) were intravenously administered 0.25 mg/kg of indocyanine green. Each laparoscopic cholecystectomy was performed under fluorescence imaging in combination with white‐light imaging. Operative outcomes including visualization of the extrahepatic biliary structures and operative time were compared between the patients on whom board‐certified surgeons operated (feasibility phase; n = 18) and the patients on whom a surgery resident operated (educational phase; n = 33).Results: There were no adverse events related to the longer interval method. The visualization rates of extrahepatic biliary structures were comparable between the two phases. Both the mean time to divide the cystic duct and the mean time to remove the gallbladder in the educational phase were significantly longer than those in the feasibility phase (68.2 vs 24.4 minutes and 30.2 vs 15.8 minutes, P < .001 each). There was no significant difference in other operative outcomes. The operative time learning curve did not decrease with a resident's experience.Conclusions: Fluorescence cholangiography with the longer interval method was feasible and could identify the extrahepatic biliary structures irrespective of the surgeon's experience; however, it did not decrease the operative time with experience.
- 15 September 2020
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 83 (5) , 1139-1145
Comprehensive Assessment of Swallowing Function Before and After Abdominal Surgery Including Thoracoabdominal Esophagectomy
- 15 September 2020
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 83 (5) , 1139-1145
Comprehensive Assessment of Swallowing Function Before and After Abdominal Surgery Including Thoracoabdominal Esophagectomy
- Open Access
- 1 August 2018
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2018 (8) , rjy214
Unusual lymph node metastasis from cancer of the thoracic esophagus
A 76-year-old male received concurrent chemoradiotherapy, at a dose of 60 Gy with low-dose 5-fluorouracil, for cT1bN0M0 squamous cell carcinoma of the mid-thoracic esophagus. Because his primary tumor relapsed with mediastinal and right supraclavicular node metastasis 4 months after completion of chemoradiotherapy, right transthoracic esophagectomy with mediastinal and right cervical lymphadenectomy was performed. However, metastatic tumors developed deep beneath the anterior border of the trapezius muscle 2 months after esophagectomy. En bloc dissection of the adipose tissue including the tumor and the transverse cervical artery was performed, followed by adjuvant radiotherapy of 50.4 Gy to the area of dissection. The patient died of pneumonia 11 months after metastasectomy, with locally recurrent disease. We have had three cases of this unusual lymph nodes metastasis from cancer of the thoracic esophagus to date and here present the characteristic imaging findings and the possible mechanism of this unusual lymph node metastasis.
- 1 August 2018
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2018 (8) , rjy214
Open AccessUnusual lymph node metastasis from cancer of the thoracic esophagus
A 76-year-old male received concurrent chemoradiotherapy, at a dose of 60 Gy with low-dose 5-fluorouracil, for cT1bN0M0 squamous cell carcinoma of the mid-thoracic esophagus. Because his primary tumor relapsed with mediastinal and right supraclavicular node metastasis 4 months after completion of chemoradiotherapy, right transthoracic esophagectomy with mediastinal and right cervical lymphadenectomy was performed. However, metastatic tumors developed deep beneath the anterior border of the trapezius muscle 2 months after esophagectomy. En bloc dissection of the adipose tissue including the tumor and the transverse cervical artery was performed, followed by adjuvant radiotherapy of 50.4 Gy to the area of dissection. The patient died of pneumonia 11 months after metastasectomy, with locally recurrent disease. We have had three cases of this unusual lymph nodes metastasis from cancer of the thoracic esophagus to date and here present the characteristic imaging findings and the possible mechanism of this unusual lymph node metastasis.
- Open Access
- 1 October 2017
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2017 (10) , rjx216
Cardiac tamponade communicating with a posterior mediastinal chylocele after esophagectomy
A 75-year-old male received neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the mid-thoracic esophagus, followed by right transthoracic esophagectomy with extended mediastinal lymphadenectomy. Cardiac tamponade developed on postoperative Days 1 and 13, for which emergency ultrasound-guided drainage was required. Pericardial drainage fluid became chylous after administration of polymeric formula. A computed tomography scan demonstrated the presence of a retrocardiac fluid collection, encompassed by the left pulmonary vein and left atrium, descending aorta and vertebral column. Based on these findings, the diagnosis of chylopericardial tamponade communicating with a posterior mediastinal chylocele was made. The ligation of the thoracic duct was successfully performed via the left-sided thoracoscopic approach on postoperative Day 20 and the clinical course after the second operation was uneventful. The possible mechanisms of this exceptionally rare complication after esophagectomy were discussed.
- 1 October 2017
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2017 (10) , rjx216
Open AccessCardiac tamponade communicating with a posterior mediastinal chylocele after esophagectomy
A 75-year-old male received neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the mid-thoracic esophagus, followed by right transthoracic esophagectomy with extended mediastinal lymphadenectomy. Cardiac tamponade developed on postoperative Days 1 and 13, for which emergency ultrasound-guided drainage was required. Pericardial drainage fluid became chylous after administration of polymeric formula. A computed tomography scan demonstrated the presence of a retrocardiac fluid collection, encompassed by the left pulmonary vein and left atrium, descending aorta and vertebral column. Based on these findings, the diagnosis of chylopericardial tamponade communicating with a posterior mediastinal chylocele was made. The ligation of the thoracic duct was successfully performed via the left-sided thoracoscopic approach on postoperative Day 20 and the clinical course after the second operation was uneventful. The possible mechanisms of this exceptionally rare complication after esophagectomy were discussed.
- 1 August 2017
- Published by Elsevier in International Journal of Surgery
- Vol. 44, 339-343
Appropriate extent of lymphadenectomy for squamous cell carcinoma of the esophagogastric junction
- 1 August 2017
- Published by Elsevier in International Journal of Surgery
- Vol. 44, 339-343
Appropriate extent of lymphadenectomy for squamous cell carcinoma of the esophagogastric junction
- 1 December 2016
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 36, 212-218
Surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity
The elucidation of the clinical impact of comorbidities is important to optimize the treatment and follow-up strategy in oesophageal cancer. We aimed to clarify the surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity. A total of 658 consecutive patients who underwent oesophagectomy for oesophageal cancer between 1985 and 2008 at our institution were enrolled. Based on the criteria of comorbidity as we defined it, we retrospectively reviewed and compared the surgical outcomes and survival between the comorbid (n = 251) and non-comorbid group (n = 407). Postoperative morbidity and mortality were not significantly different between the two groups. The 5-year overall survival rate of the comorbid group was significantly lower (39.3% vs. 45.2%, adjusted HR = 1.31, 95% CI: 1.07-1.62) but the 5-year disease-specific survival rate was not significantly different between the comorbid and non-comorbid groups (53.9% vs. 53.1%, adjusted HR = 1.11, 95% CI: 0.86-1.42). The 5-year incidence rate of death from other diseases in the comorbid group was significantly higher than that in the non-comorbid group (26.7% vs. 14.8%, P < 0.01). The leading cause of death from other diseases was pneumonia. Oesophagectomy in oesophageal cancer patients with comorbidity can be safely performed. However, the overall survival after oesophagectomy in these patients was unfavorable because of the high incidence of death from other diseases, especially pneumonia.
- 1 December 2016
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 36, 212-218
Surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity
The elucidation of the clinical impact of comorbidities is important to optimize the treatment and follow-up strategy in oesophageal cancer. We aimed to clarify the surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity. A total of 658 consecutive patients who underwent oesophagectomy for oesophageal cancer between 1985 and 2008 at our institution were enrolled. Based on the criteria of comorbidity as we defined it, we retrospectively reviewed and compared the surgical outcomes and survival between the comorbid (n = 251) and non-comorbid group (n = 407). Postoperative morbidity and mortality were not significantly different between the two groups. The 5-year overall survival rate of the comorbid group was significantly lower (39.3% vs. 45.2%, adjusted HR = 1.31, 95% CI: 1.07-1.62) but the 5-year disease-specific survival rate was not significantly different between the comorbid and non-comorbid groups (53.9% vs. 53.1%, adjusted HR = 1.11, 95% CI: 0.86-1.42). The 5-year incidence rate of death from other diseases in the comorbid group was significantly higher than that in the non-comorbid group (26.7% vs. 14.8%, P < 0.01). The leading cause of death from other diseases was pneumonia. Oesophagectomy in oesophageal cancer patients with comorbidity can be safely performed. However, the overall survival after oesophagectomy in these patients was unfavorable because of the high incidence of death from other diseases, especially pneumonia.
- 1 November 2015
- Vol. 42 (12) , 1559-60
[Usefulness of Palliative Gastrojejunal Bypass Surgery].
The aim of this study was to evaluate the usefulness of gastrojejunal bypass surgery performed in patients presenting with upper gastrointestinal tract obstruction due to unresectable advanced cancer. The subjects were 21 patients who underwent gastrojejunal bypass surgery at our division between 2010 and 2014 for symptom palliation. We retrospectively evaluated the operative outcomes, whether chemotherapy was administered, the oral ingestion period, and survival time. The median postoperative day of starting oral ingestion was 6 (range: 2-42), and the median period from decreased oral ingestion to death was 4 (range: 0-26) days. Twelve patients (57%) were discharged. Postoperative chemotherapy was prescribed to all the 9 patients who desired treatment. The median duration of oral digestion time was 61 days, and the median overall survival time was 92 days. Gastrojejunal bypass surgery is found to have the potential to not only make relatively long-term oral ingestion possible, but also broaden available treatment options, such as home care or chemotherapy, thereby contributing to improved quality of life.
- 1 November 2015
- Vol. 42 (12) , 1559-60
[Usefulness of Palliative Gastrojejunal Bypass Surgery].
The aim of this study was to evaluate the usefulness of gastrojejunal bypass surgery performed in patients presenting with upper gastrointestinal tract obstruction due to unresectable advanced cancer. The subjects were 21 patients who underwent gastrojejunal bypass surgery at our division between 2010 and 2014 for symptom palliation. We retrospectively evaluated the operative outcomes, whether chemotherapy was administered, the oral ingestion period, and survival time. The median postoperative day of starting oral ingestion was 6 (range: 2-42), and the median period from decreased oral ingestion to death was 4 (range: 0-26) days. Twelve patients (57%) were discharged. Postoperative chemotherapy was prescribed to all the 9 patients who desired treatment. The median duration of oral digestion time was 61 days, and the median overall survival time was 92 days. Gastrojejunal bypass surgery is found to have the potential to not only make relatively long-term oral ingestion possible, but also broaden available treatment options, such as home care or chemotherapy, thereby contributing to improved quality of life.
- 1 November 2015
- Vol. 42 (12) , 1597-9
[A Case of Long-Term Survival Following Metastasectomies of Liver Metastasis, Lung Metastasis, and Peritoneal Dissemination of Cecal Cancer].
The patient was a 73-year-old woman. She underwent right hemicolectomy and D3 lymph node dissection for cecal cancer in June 2003. Although a peritoneal dissemination was intraoperatively noted around the primary tumor lesion, it was resected concurrently and thus R0 surgery was accomplished. Postoperative adjuvant chemotherapy was not performed. During the follow-up on an outpatient basis, a solitary left lung metastasis was found and partial left upper lobectomy of the lung was performed in December 2004. A solitary liver metastasis was identified in the liver (S3), and lateral segmentectomy of the liver was performed in June 2007. The patient was alive with no evidence of recurrence 11 years and 9 months after resection of the primary lesion and 7 years and 9 months after the hepatectomy. Long-term survival can be achieved by performing resection without residual cancer even in some cases with metachronous metastatic recurrences in multiple organs. Metastasectomy should be considered proactively when the patient is in a good general condition and R0 resection is possible.
- 1 November 2015
- Vol. 42 (12) , 1597-9
[A Case of Long-Term Survival Following Metastasectomies of Liver Metastasis, Lung Metastasis, and Peritoneal Dissemination of Cecal Cancer].
The patient was a 73-year-old woman. She underwent right hemicolectomy and D3 lymph node dissection for cecal cancer in June 2003. Although a peritoneal dissemination was intraoperatively noted around the primary tumor lesion, it was resected concurrently and thus R0 surgery was accomplished. Postoperative adjuvant chemotherapy was not performed. During the follow-up on an outpatient basis, a solitary left lung metastasis was found and partial left upper lobectomy of the lung was performed in December 2004. A solitary liver metastasis was identified in the liver (S3), and lateral segmentectomy of the liver was performed in June 2007. The patient was alive with no evidence of recurrence 11 years and 9 months after resection of the primary lesion and 7 years and 9 months after the hepatectomy. Long-term survival can be achieved by performing resection without residual cancer even in some cases with metachronous metastatic recurrences in multiple organs. Metastasectomy should be considered proactively when the patient is in a good general condition and R0 resection is possible.